Financing type: at-the-market prospectus offering
Gross proceeds: $10,026,050 (U.S.) in the quarter ended March 31, 2026, on the New York Stock Exchange
Offering: 2,267,842 common listed shares sold on the NYSE
Offering price: an average price of $4.86 (U.S.) per listed share on the NYSE
Disclosure: Refer to the new base shelf prospectus dated July 30, 2025, and the
company's news release dated Jan. 9, 2026, and April 10, 2026.
© 2026 Canjex Publishing Ltd. All rights reserved.